Intelligence Β· Patent portfolio
Nektar Therapeutics UK Patents
Full USPTO pharma patent portfolio for Nektar Therapeutics UK β grant dates, expiration, and drug cross-links.
- Patents
- 423
- Expiring β€24m
- 24
Quick answer
Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β use filters for patent-cliff planning.
-
US 9775911
Composition comprising a polymeric reagent
granted -
US 9763995
Polymer conjugates of protegrin peptides
granted -
US 9732189
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 9725431
Oligomer-tricyclic conjugates
granted -
US 9700529
Particulate materials
granted -
US 9688638
Opioid agonists and uses thereof
granted -
US 9682988
Solid salt form of Ξ±-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
granted -
US 9682153
Polymer conjugates of therapeutic peptides
granted -
US 9670235
Oligomer-foscarnet conjugates
granted -
US 9636412
Conjugates of an anti-TNF-alpha antibody
granted -
US 9616136
N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
granted -
US 9617228
Oligomer-containing substituted aromatic triazine compounds
granted -
US 9616060
Particulate materials
granted -
US 9579392
Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
granted -
US 9539337
Compositions comprising two different populations of polymer-active agent conjugates
granted -
US 9540330
Oligomer-containing hydantoin compounds
granted -
US 9512135
Oligomer-opioid agonist conjugates
granted -
US 9504755
Multi-arm polymeric alkanoate conjugates
granted -
US 9493544
Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
granted -
US 9493609
N-maleimidyl polymer derivatives
granted -
US 9487473
Oligomer-amino acid conjugates
granted -
US 9458166
Oligomer-opioid agonist conjugates
granted -
US 9446139
Polymer-based compositions and conjugates of HIV entry inhibitors
granted -
US 9433684
Conjugates of small-interfering nucleic acids
granted -
US 9421204
Oligomer modified diaromatic substituted compounds
granted -
US 9421275
Oligomer-calcimimetic conjugates and related compunds
granted -
US 9399070
Compositions comprising a polymeric reagent and a pharmacologically active agent
granted -
US 9399033
Oligomer-containing pyrrolidine compounds
granted -
US 9388104
Chemically modified small molecules
granted -
US 9381254
Methods for preparing polymeric reagents
granted -
US 9375486
Oligomer-containing benzamide-based compounds
granted -
US 9365604
Oligomer-nucleoside phosphate conjugates
granted -
US 9346917
Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
granted -
US 9347054
Polymer factor IX moiety conjugates
granted -
US 9339459
Particulate materials
granted -
US 9333267
Thiol-selective water-soluble polymer derivatives
granted -
US 9334364
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 9333200
Multi-arm polymer prodrugs
granted -
US 9320808
Acid salt forms of polymer-drug conjugates and alkoxylation methods
granted -
US 9314463
Oligomer-diarylpiperazine conjugates
granted -
US 9308273
Polymer derivatives comprising an acetal or ketal branching point
granted -
US 9308274
Stabilized polymeric thiol reagents
granted -
US 9266845
Oligomer-containing substituted aromatic triazine compounds
granted -
US 9233932
Oligomer-nitroimidazole anti-infective conjugates
granted -
US 9233169
Oligomer-bis-chromonyl compound conjugates
granted -
US 9233167
Oligomer-opioid agonist conjugates
granted -
US 9233168
Oligomer-opioid agonist conjugates
granted -
US 9233165
Oligomer-aryloxy-substituted propanamine conjugates
granted
Frequently asked questions
How many patents does Nektar Therapeutics UK have?
423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Nektar Therapeutics UK patents expire?
24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory